Efficacy of 5% imiquimod cream in a patient with classic kaposi sarcoma

Simple item page
dc.contributor.authorGündüz K.
dc.contributor.authorGünay Ü.
dc.contributor.authorInanir I.
dc.contributor.authorGençoǧlan G.
dc.contributor.authorTemiz P.
dc.date.accessioned2024-07-22T08:19:03Z
dc.date.available2024-07-22T08:19:03Z
dc.date.issued2012
dc.description.abstractBackground: The classic Kaposi sarcoma is most common in the Mediterranean po-pulation over 50 years of age and presents with reddish-brown papules and nodules particularly on the lower limbs. Treatment depends on the clinical presentation and extension of lesions. Imiquimod is as an immune response modifier with antiangio-genic activity. Main observations: We present a 74-year-old man with classic Kaposi sarcoma who had multiple, small, violaceous papules and nodules on the trunk and extremities with a history of 14 years. He complained particularly from plantar hyperkeratotic painful nodules. Treatment with imiquimod 5% cream under occlusion resulted with almost complete regression within 12 weeks. No local or systemic side effects were observed. Conclusions: Topical imiquimod was a safe and effective therapy in our patient with classic Kaposi sarcoma.
dc.identifier.DOI-ID10.3315/jdcr.2012.1099
dc.identifier.issn18987249
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/17482
dc.language.isoEnglish
dc.rightsAll Open Access; Green Open Access
dc.subjectimiquimod
dc.subjectaged
dc.subjectarticle
dc.subjectcase report
dc.subjectdrug efficacy
dc.subjectfollow up
dc.subjecthisopathology
dc.subjecthuman
dc.subjecthuman tissue
dc.subjectKaposi sarcoma
dc.subjectmale
dc.subjectpapule
dc.subjectskin nodule
dc.subjecttumor regression
dc.titleEfficacy of 5% imiquimod cream in a patient with classic kaposi sarcoma
dc.typeArticle

Files

Collections

Scopus Koleksiyonu